
News|Articles|July 1, 2002
Congress expands drug safety surveillance as part of bioterrorism bill
Just before leaving Washington for the Memorial Day recess in May, Congress approved legislation to enhance the ability of hospitals and public health agencies to respond to bioterrorist threats.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
Studies of tafasitamab and epcoritamab
2
Dosing schedules of combination approaches
3
A conversation with Julia S. Feldman, Ph.D., about taking impairment and context into consideration when diagnosing preschoolers with ADHD
4
The connectivity layer payer AI is missing
5























